Cyclin D1 and LEF-1 (Lymphoid Enhancer Binding Factor 1) are overexpressed in colon cancer and have been identified as the target genes of miR-449a in human prostate cancer and mesenchymal stem cells (31, 32). This evidence concerns the gene CCND1 and prostate cancer.